Pfizer/BioNTech vaccines
The Latest
-
Pfizer COVID-19 Pill Gets Emergency Use Authorization In South Korea
Countries are rushing to embrace Pfizer's pill as their first line of defense. 
Countries are rushing to embrace Pfizer's pill as their first line of defense. -
U.S. FDA Authorizes Pfizer COVID-19 Third Shot For Older, High-Risk Americans
Around 2.3 million people in the U.S. have already received their third jabs of the Pfizer vaccine. 
Around 2.3 million people in the U.S. have already received their third jabs of the Pfizer vaccine.
